Physician profile
Cuie Qiu
NPI 1972738045
$9,432.25
in general payments reported to CMS, 2019-2025
73 companies · $1,963 in 2025
The $1,963 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,638 · 2020: $422 · 2021: $1,254 · 2022: $1,356 · 2023: $1,248 · 2024: $1,551 · 2025: $1,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,761.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,246.15 | 2021-2025 | |
| Amgen INC. | $790.64 | 2019-2025 | Evenity, Prolia, Repatha |
| Novartis Pharmaceuticals Corporation | $774.64 | 2019-2025 | |
| Argenx US, INC. | $558.91 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $519.09 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Pfizer INC. | $408.72 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $389.66 | 2019-2023 | Ajovy |
| Sunovion Pharmaceuticals INC. | $342.14 | 2019-2022 | |
| Radius Health, INC. | $251.95 | 2020-2025 | Tymlos |
| Lilly USA, LLC | $250.77 | 2019-2025 | Jardiance, Zepbound, Kisunla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.10 | 2021-2025 | Xifaxan |
| Emd Serono, INC. | $181.09 | 2019-2022 | |
| Ibsa Pharma INC. | $178.90 | 2022-2025 | Licart, Tirosint, Flector |
| Otsuka America Pharmaceutical, INC. | $171.84 | 2024-2025 | Rexulti |
| Alexion Pharmaceuticals, INC. | $164.45 | 2019-2025 | Ultomiris, Strensiq |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuie Qiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.